Deramciclane fumarate

N/A

Report date: 2022/05/12 17:20:37
NME

Base Information

Drug NameDeramciclane fumarate
Drug Alias Name富马酸德伦环烷deramciclano德伦环烷deramciclanumEGIS-3886 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA uptake inhibitorsSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorGABA transporter 1Serotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis PharmaceuticalsPfizer IncOrion Corp
Active IndicationsN/A
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksWikipedia